SUMMARY
T he presence of immunoreactive glucagon (IRG) in the plasma of totally pancreatectomized dogs can be accounted for by the presence of A-cells in the oxyntic mucosa of the stomach, 1 " 4 but the source of the ~3500 mol. wt. IRG in the plasma of pancreatectomized humans 5 -6 has not been identified. For example, Munoz-Barragan et al. 7 reported A-cells in only one of eight specimens obtained at autopsy. Even surgically obtained specimens of human stomach do not seem to contain significant amounts of glucagon. 8 In the past, identification of extrapancreatic Acells in humans has been based entirely on purely morphologic criteria, such as the similarity of that aspect of their secretory granules with that of pancreatic A-cells. 9>1° With the use of a new immunocytochemical probe, the protein Agold technique, 11 which ensures improved definition of immunoreactive sites and optimal preservation of cellular morphology, we now report the identification in the fetal gastric mucosa of endocrine cells that are ultrastructurally and immunochemically indistinguishable from pancreatic A-cells.
MATERIALS AND METHODS
Tissue. Gastric fundic mucosa from three fetuses, 13-15 wk gestational age, was studied. The preparation of the tissue for the electron microscopy was detailed in a previously published study 12 to which the three fetuses belong. Protein A-gold (pAg) technique. Protein A-gold (pAg) complex was prepared in our laboratory as previously reported. 11 Thin sections of fundic mucosa were collected on nickel grids and processed by the pAg technique as follows. First, the sections were incubated overnight at 4°C with the specific antisera diluted 1:100. After careful washing in distilled water to remove unbound and nonspecifically bound antibody, the sections were incubated with the pAg solution (diluted 1:25) for 1 h at room temperature. By this step, the sites of binding between antigenic sites and antibodies are labeled by the protein A-coated gold particles (diameter ~20 nm). Sections were counterstained with uranyl acetate and lead citrate, and examined with a Philips EM 301 electron microscope. Antisera. The 15K antiglucagon serum and the R64 antiglicentin serum were applied. These antisera have been previously characterized.
13 ' 14 15K Antiserum is a C-terminal antiglucagon serum that does not react with extracts containing gut glucagon-like immunoreactivity (GLI). R64 Antiglicentin serum (a gift of A. J. Moody, Bagsvaerd, Denmark) recognizes the N-terminus of the glucagon-containing peptide glicentin, outside the glucagon sequence, and does not react significantly with glucagon.
RESULTS AND DISCUSSION
In thin sections of the gastric mucosa of all three fetuses studied, a sparse population of granule-containing cells reacting with both antiglucagon and antiglicentin antisera was detected ( Figures 1A and 2A) . Their secretory granules often showed the characteristic partition of the content into a dense central core surrounded by a less dense mantle (Figures 1A and 2A) , a pattern typical of the pancreatic A-cell 15 ( Figures 1B and 2B) . Note, however, that homogenously dense granules could predominate in some immunoreactive cells. In double-cored secretory granules, the glucagon immunoreactive sites were concentrated in the dense core ( Figure 1 ) while the glicentin immunoreactive sites were mostly located over the paler mantle (Figure 2 ). This topographical distribution is characteristic of the pancreatic asecretory granules. 13 These results demonstrate that the gastric mucosa of human fetuses contains cells indistinguishable from the pancreatic A-cell on morphologic and immunocytochemical criteria. They suggest, at least in the fetus, that the stomach might be a potential source for extrapancreatic IRG in humans.
Obviously, these results in fetuses do not necessarily explain the glucagonemia of depancreatized adults. 5 " 6 Perhaps the presence of glucagon cells in the human colon 16 and/or conversion of gut GLI to glucagon 17 provide better explanations.
